CO6270172A2 - Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus - Google Patents

Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus

Info

Publication number
CO6270172A2
CO6270172A2 CO10025154A CO10025154A CO6270172A2 CO 6270172 A2 CO6270172 A2 CO 6270172A2 CO 10025154 A CO10025154 A CO 10025154A CO 10025154 A CO10025154 A CO 10025154A CO 6270172 A2 CO6270172 A2 CO 6270172A2
Authority
CO
Colombia
Prior art keywords
streptococcus
protein
identifying
serotypes
immune response
Prior art date
Application number
CO10025154A
Other languages
English (en)
Spanish (es)
Inventor
Hilda Elizabeth Smith
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CO6270172A2 publication Critical patent/CO6270172A2/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
CO10025154A 2007-08-06 2010-03-03 Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus CO6270172A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07113844A EP2023143A1 (en) 2007-08-06 2007-08-06 Immunogenic streptococcus proteins

Publications (1)

Publication Number Publication Date
CO6270172A2 true CO6270172A2 (es) 2011-04-20

Family

ID=38890252

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10025154A CO6270172A2 (es) 2007-08-06 2010-03-03 Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus

Country Status (19)

Country Link
US (1) US20100297183A1 (enExample)
EP (3) EP2023143A1 (enExample)
JP (2) JP5462164B2 (enExample)
KR (1) KR20100063706A (enExample)
CN (1) CN101821627A (enExample)
AR (1) AR067830A1 (enExample)
AU (1) AU2008284491A1 (enExample)
BR (1) BRPI0815604A2 (enExample)
CA (1) CA2695721A1 (enExample)
CL (1) CL2008002320A1 (enExample)
CO (1) CO6270172A2 (enExample)
DK (1) DK2183597T3 (enExample)
ES (1) ES2432407T3 (enExample)
MX (1) MX2010001482A (enExample)
RU (1) RU2518315C2 (enExample)
TW (1) TW200911999A (enExample)
UA (1) UA103885C2 (enExample)
WO (1) WO2009020391A1 (enExample)
ZA (1) ZA201000806B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL204863B1 (pl) 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
AU2002230275A1 (en) * 2001-02-02 2002-08-12 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence ofstreptococcus suis
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
WO2015042369A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
JP2018504381A (ja) * 2014-12-22 2018-02-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 細胞透過性ペプチド
RU2757426C2 (ru) 2015-10-21 2021-10-15 МинерваКС Апс Иммунногенный слитый белок
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2685957C2 (ru) * 2016-12-28 2019-04-23 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Химерный рекомбинантный белок, обладающий протективными свойствами в отношении Streptococcus pyogenes
US20240024380A1 (en) * 2020-12-23 2024-01-25 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells
CN112773891B (zh) * 2021-02-01 2022-03-25 北部湾大学 卵形鲳鲹源无乳链球菌dna疫苗及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283507A (en) 1990-12-20 1994-02-01 General Electric Company Regenerative braking protection for an electrically-propelled traction vehicle
NL9100510A (nl) * 1991-03-21 1992-10-16 Centraal Diergeneeskundig Inst Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens.
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
EP0750042A1 (fr) * 1995-06-20 1996-12-27 Societe Des Produits Nestle S.A. Bactéries lactiques produisant des exopolysaccharides
PT900380E (pt) 1996-04-26 2003-12-31 Univ Leiden Metodos para seleccionar e produzir epitopos peptidicos de celulas t e vacinas que incorporam os referidos epitopos seleccionados
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
PL204863B1 (pl) * 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
PT1140157E (pt) * 1998-12-21 2009-05-06 Medimmune Inc Proteínas de streptococcus pneumoniae e fragmentos imunogénicos para vacinas
ATE405636T1 (de) * 1999-06-16 2008-09-15 Boston Biomedical Res Inst Immunologische kontrolle des beta-amyloid gehaltes in vivo
PT1294771E (pt) * 2000-06-12 2009-01-06 Univ Saskatchewan Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
EP1205552A1 (en) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence of streptococci, involving ORFs from Streptococcus suis
AU2002230275A1 (en) * 2001-02-02 2002-08-12 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes, involved in the virulence ofstreptococcus suis
US7517955B2 (en) * 2002-11-26 2009-04-14 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
WO2004067559A1 (en) * 2003-01-27 2004-08-12 Københavns Universitet Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
CA2525540A1 (en) * 2003-05-30 2004-12-09 Intercell Ag Enterococcus antigens
WO2006048763A1 (en) * 2004-11-05 2006-05-11 Pharmacia & Upjohn Company Llc Anti-bacterial vaccine compositions
PT2029173T (pt) * 2006-06-26 2016-11-02 Macrogenics Inc Anticorpos específicos fc rib e seus métodos de uso

Also Published As

Publication number Publication date
MX2010001482A (es) 2010-03-01
ES2432407T3 (es) 2013-12-03
TW200911999A (en) 2009-03-16
BRPI0815604A2 (pt) 2015-03-03
JP2010535500A (ja) 2010-11-25
JP2014095721A (ja) 2014-05-22
EP2183597B1 (en) 2013-07-24
EP2660604A2 (en) 2013-11-06
US20100297183A1 (en) 2010-11-25
AR067830A1 (es) 2009-10-21
KR20100063706A (ko) 2010-06-11
CA2695721A1 (en) 2009-02-12
ZA201000806B (en) 2010-10-27
AU2008284491A1 (en) 2009-02-12
RU2518315C2 (ru) 2014-06-10
CL2008002320A1 (es) 2009-09-25
EP2183597A1 (en) 2010-05-12
CN101821627A (zh) 2010-09-01
JP5462164B2 (ja) 2014-04-02
RU2010107878A (ru) 2011-09-20
EP2660604A3 (en) 2014-02-12
UA103885C2 (en) 2013-12-10
EP2023143A1 (en) 2009-02-11
WO2009020391A1 (en) 2009-02-12
DK2183597T3 (da) 2013-10-14

Similar Documents

Publication Publication Date Title
CO6270172A2 (es) Metodo para identificar una proteina streptococcus y composiciones inmunogenicas capaces de provocar una respuesta inmune contra por lo menos dos cepas y/o serotipos de streptococcus
ES2621211T3 (es) Composiciones inmunogénicas que comprenden polipéptidos de mycobacterium tuberculosis y fusiones de los mismos
ES2564026T3 (es) Antígenos de micobacterias
BR112012012460A8 (pt) método de liofilização, composições e kits
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2011008349A3 (en) Methods of identifying infectious disease and assays for identifying infectious disease
CO6260103A2 (es) Composiciones que comprenden antigenos neumococidos
ES2562774T3 (es) Vacunas para la gripe basadas en el virus del mosaico de la papaya
WO2008070229A3 (en) Detection of pathogenic aggregates of protein in a sample by homologous elisa
WO2008108830A3 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
BR112015009541A2 (pt) novos adjuvantes de mucosa e sistemas de aplicação
WO2011055968A3 (en) Kit for detecting bacterial infection comprising novel monoclonal antibodies
ES2531115T3 (es) Combinaciones de clados de RrgB neumocócicos
WO2008127094A3 (en) New virulence factors of streptococcus pnuemoniae
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
CL2008001520A1 (es) Procedimiento para detectar la virulencia de una cepa de helicobacter pylori; y kit de deteccion de dichas cepas
BR112016015812A2 (pt) Método para aumentar a biomassa e o conteúdo lipídico em um microrganismo e um microrganismo geneticamente modificado exibindo autofagia reforçada
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
ATE469310T1 (de) Lamellenkupplungseinrichtung
CU24709B1 (es) Ácido nucleico que codifica la proteína de superficie neumocócica a1 (pspa1) truncada, constructo de expresión para la expresión de alto nivel de la misma y vacuna conjugada neumocócica
WO2006078975A3 (en) Improved vaccine against feline calicivirus
WO2010046778A3 (en) Novel shigella frotein antigens and methods
WO2006117538A3 (en) Assays for diagnosis of tuberculosis and uses thereof
ECSP11010772A (es) Inhibidor de infección
WO2007075308A3 (en) Vaccine candidates against johne's disease

Legal Events

Date Code Title Description
FC Application refused